Patents Represented by Attorney, Agent or Law Firm Ann R. Pokalsky
-
Patent number: 6710227Abstract: Provided are DNA sequences encoding cyclin-dependent kinase inhibitor(s) as well as to methods for obtaining the same. Furthermore, vectors comprising said DNA sequences are described, wherein the DNA sequences are operatively linked to regulatory elements allowing expression in prokaryotic and/or eukaryotic host cells. In addition, proteins encoded by said DNA sequences, antibodies to said proteins and methods for their production are provided. Furthermore, regulatory sequences which naturally regulate the expression of the above described DNA sequences are described. Also described is a method for controlling or altering growth characteristics of a plant and/or a plant cell comprising introduction and/or expression of one or more cyclin-dependent kinase inhibitor(s) functional in a plant or parts thereof and/or one or more DNA sequences encoding such proteins.Type: GrantFiled: March 16, 2000Date of Patent: March 23, 2004Assignee: CropDesign N.V.Inventors: Dirk Inze, Lieven De Veylder, Janice De Almeida, Isabelle Landrieu
-
Patent number: 6541254Abstract: The present invention provides a highly glycosylated iduronate-2-sulfatase enzyme comprising an iduronate-2-sulfatase polypeptide with at least 5 kilodalton (kDa) more sugar than iduronate-2-sulfatase purified from a natural source, e.g. human liver. The present invention also provides an enzymatically active polypeptide fragment or variant of such a highly glycosylated iduronate-2-sulfatase. The present invention further provides an isolated nucleic acid encoding iduronate-2-sulfatase, as well as an expression vector, a host cell and a method for producing the present highly glycosylated iduronate-2-sulfatase enzyme.Type: GrantFiled: October 10, 2000Date of Patent: April 1, 2003Assignee: Women's and Children's HospitalInventors: Peter J. Wilson, Charles Phillip Morris, Donald Stewart Anson, Teresa Occhiodoro, Julie Bielicki, Peter Roy Clements, John Joseph Hopwood
-
Patent number: 6524835Abstract: The present invention relates generally to &agr;-L-iduronidase and to genetic sequences encoding same. More particularly, the present invention provides an isolated nucleic acid molecule comprising a sequence of nucleotides which encodes or are complementary to a sequence which encodes a mammalian &agr;-L-iduronidase or fragment or derivative thereof and to the recombinant enzyme encoded thereby. These molecules are useful in the investigation, diagnosis and treatment of subjects suspected of or suffering from &agr;-L-iduronidase deficiency.Type: GrantFiled: August 16, 2000Date of Patent: February 25, 2003Assignee: Women's and Children's HospitalInventors: Hamish Steel Scott, Donald Stewart Anson, Annette Marie Orsborn, Paul Victor Nelson, Peter Roy Clements, Charles Phillip Morris, John Joseph Hopwood
-
Patent number: 6491913Abstract: The present invention relates generally to mammalian sulphamidase and to genetic sequences encoding same and to the use of these in the investigation, diagnosis and treatment of subjects suspected of or suffering from sulphamidase deficiency.Type: GrantFiled: December 4, 2000Date of Patent: December 10, 2002Assignee: Women's and Children's HospitalInventors: John Joseph Hopwood, Hamish Steele Scott, Craig Geoffrey Freeman, Charles Phillip Morris, Lianne Cheryl Blanch, Xiao Hui Guo
-
Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
Patent number: 6465718Abstract: The present invention provides a new Arabidopsis thaliana nucleotide sequence and polypeptide sequence having a molecular weight of about 10.5 kDa. Modulation of the expression of the polypeptides encoded by the nucleotide sequences according to the invention has an advantageous influence on plant cell division characteristics especially on the endoreduplication whereby plant cell size and storage capacity of plant cells is influenced.Type: GrantFiled: March 13, 2000Date of Patent: October 15, 2002Assignee: CropDesign N.V.Inventors: Dirk Inze, Gerda Segers, Lieven De Veylder, Vladimir Mironov -
Patent number: 6458579Abstract: The present invention relates generally to mammalian sulphamidase and to genetic sequences encoding same and to the use of these in the investigation, diagnosis and treatment of subjects suspected of or suffering from sulphamidase deficiency.Type: GrantFiled: December 4, 2000Date of Patent: October 1, 2002Assignee: Women's and Children's HospitalInventors: John Joseph Hopwood, Hamish Steele Scott, Craig Geoffrey Freeman, Charles Phillip Morris, Lianne Cheryl Blanch, Xiao Hui Guo
-
Patent number: 6255096Abstract: The present invention relates generally to mammalian &agr;-N-acetyglucosaminidase and to genetic sequences encoding same and to their use in the investigation, diagnosis and treatment of subjects suspected of or suffering from &agr;-N-acetylglucosaminidase deficiency.Type: GrantFiled: April 22, 1999Date of Patent: July 3, 2001Assignee: Women's and Children's HospitalInventors: John Joseph Hopwood, Hamish Steele Scott, Birgit Weber, Lianne Blanch, Donald Stewart Anson
-
Patent number: 6238662Abstract: The present invention relates generally to &agr;-L-iduronidase and to genetic sequences encoding same. More particularly, the present invention provides an isolated nucleic acid molecule comprising a sequence of nucleotides which encodes or are complementary to a sequence which encodes a mammalian &agr;-L-iduronidase or fragment or derivative thereof and to the recombinant enzyme encoded thereby. These molecules are useful in the investigation, diagnosis and treatment of subjects suspected of or suffering from &agr;-L-iduronidase deficiency.Type: GrantFiled: August 30, 1999Date of Patent: May 29, 2001Assignee: Women's and Children's HospitalInventors: Hamish Steel Scott, Donald Stewart Anson, Annette Marie Orsborn, Paul Victor Nelson, Peter Roy Clements, Charles Phillip Morris, John Joseph Hopwood
-
Patent number: 6200563Abstract: The present invention relates generally to mammalian sulphamidase and to genetic sequences encoding same and to the use of these in the investigation, diagnosis and treatment of subjects suspected of or suffering from sulphamidase deficiency.Type: GrantFiled: August 9, 1999Date of Patent: March 13, 2001Assignee: Women's and Children's HospitalInventors: John Joseph Hopwood, Hamish Steele Scott, Craig Geoffrey Freeman, Charles Phillip Morris, Lianne Cheryl Blanch, Xiao Hui Guo
-
Patent number: 6153188Abstract: The present invention provides a highly glycosylated iduronate-2-sulfatase enzyme comprising an iduronate-2-sulfatase polypeptide with at least 5 kilodalton (kDa) more sugar than iduronate-2-sulfatase purified from a natural source, e.g. human liver. The present invention also provides an enzymatically active polypeptide fragment or variant of such a highly glycosylated iduronate-2-sulfatase. The present invention further provides an isolated nucleic acid encoding iduronate-2-sulfatase, as well as an expression vector, a host cell and a method for producing the present highly glycosylated iduronate-2-sulfatase enzyme.Type: GrantFiled: February 12, 1999Date of Patent: November 28, 2000Assignee: Women's and Children's HospitalInventors: Peter J. Wilson, Charles Phillip Morris, Donald Stewart Anson, Teresa Occhiodoro, Julie Bielicki, Peter Roy Clements, John Joseph Hopwood
-
Patent number: 6149909Abstract: The present invention relates generally to .alpha.-L-iduronidase and to genetic sequences encoding same. More particularly, the present invention provides an isolated nucleic acid molecule comprising a sequence of nucleotides which encodes or are complementary to a sequence which encodes a mammalian .alpha.-L-iduronidase or fragment or derivative thereof and to the recombinant enzyme encoded thereby. These molecules are useful in the investigation, diagnosis and treatment of subjects suspected of or suffering from .alpha.-L-iduronidase deficiency.Type: GrantFiled: November 13, 1998Date of Patent: November 21, 2000Assignee: Women's and Children's HospitalInventors: Hamish Steele Scott, Donald Stewart Anson, Annette Marie Orsborn, Paul Victor Nelson, Peter Roy Clements, Charles Phillip Morris, John Joseph Hopwood